Doctors use ejection fraction percentages to categorize left-sided heart failure. According to a 2022 article, people with HFpEF have an ejection fraction of more than 50%.

It has specific treatments depending on the type of amyloidosis, in addition to the treatments mentioned above for heart failure. Dear Dr. Roach: I am just getting over the horrible shingles.

A new study published in the European Journal of Medical Research revealed that dapagliflozin, a sodium-glucose ...

Overall, SGLT2 inhibitors show clear benefits in both heart failure with reduced ejection fraction (HFrEF) and HFpEF populations, while sacubitril-valsartan is emerging as an important HFpEF therapy.

Source Reference: Oraii A, et al "Atrial fibrillation ablation in heart failure with reduced vs preserved ejection fraction: a systematic review and meta-analysis" JAMA Cardiol 2024; DOI: 10.1001 ...

Solomon, S. D., et al. (2024) Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. New England Journal of Medicine. doi.org/10.1056/NEJMoa2407107.

Given the current trends, heart failure with normal ejection fraction will become the most common form of heart failure, for which we do not currently have an evidence-based successful treatment.

Mc Causland FR, Claggett BL, Vaduganathan M, et al. Decline in estimated glomerular filtration rate after dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: a ...

In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone reduced risk for CV death and worsening HF by 16% compared with placebo, researchers reported at the ...

For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ventricular (LV) diastolic function, according to a study published online Sept ...